Stock Scorecard
Stock Summary for Smith & Nephew plc (SNN) - $23.88 as of 4/26/2024 3:47:18 PM EST
Total Score
13 out of 29
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for SNN
Positive earnings growth | |
P/E ratio less than Industry P/E Ratio | |
P/E ratio less than Sector P/E Ratio | |
P/E ratio that is half the growth rate (or less) | |
Positive net cash position the past year and most recent quarter | |
Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
Positive net income past year and 12 trailing months | |
Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for SNN
Revenue growing by at least 20% average per year over the last 5 years | |
Market Capitalization under 2 billion | |
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for SNN
Declared an ex-dividend date | |
Forward annual dividend rate greater than 2 | |
Positive net cash position the past year and most recent quarter | |
Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
Current ratio most recent quarter greater than 2 |
Bonus Criteria for SNN
P/E ratio less than five-year Average P/E ratio | |
Last Price to 52 Week Low Ratio Less Than 1 | |
Total Cash Per Share > Last Day Price | |
P/S Ratio < 1 | |
P/B Ratio < 1 |
Latest News for for SNN
Financial Details for SNN
Company Overview |
|
---|---|
Ticker | SNN |
Company Name | Smith & Nephew plc |
Country | USA |
Description | Smith & Nephew plc develops, manufactures, markets and sells medical devices worldwide. The company is headquartered in Watford, the United Kingdom. |
Sector Name | LIFE SCIENCES |
Industry Name | ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES |
Most Recent Quarter | 12/31/2023 |
Next Earnings Date | 5/2/2024 |
Stock Price History |
|
Last Day Price | 23.88 |
Last Day Price Updated | 4/26/2024 3:47:18 PM EST |
Last Day Volume | 0 |
Average Daily Volume | 939,013 |
52-Week High | 31.80 |
52-Week Low | 21.12 |
Last Price to 52 Week Low | 13.07% |
Valuation Measures |
|
Trailing PE | 40.95 |
Industry PE | 60.69 |
Sector PE | 56.64 |
5-Year Average PE | 48.42 |
Free Cash Flow Ratio | 34.61 |
Industry Free Cash Flow Ratio | 37.87 |
Sector Free Cash Flow Ratio | 30.65 |
Current Ratio Most Recent Quarter | 1.77 |
Total Cash Per Share | 0.69 |
Book Value Per Share Most Recent Quarter | 5.98 |
Price to Book Ratio | 1.99 |
Industry Price to Book Ratio | 6.35 |
Sector Price to Book Ratio | 22.15 |
Price to Sales Ratio Twelve Trailing Months | 1.94 |
Industry Price to Sales Ratio Twelve Trailing Months | 7.00 |
Sector Price to Sales Ratio Twelve Trailing Months | 5.17 |
Share Statistics |
|
Total Shares Outstanding | 437,167,000 |
Market Capitalization | 10,439,547,960 |
Institutional Ownership | N/A |
Dividends |
|
Ex-Dividend Date | 4/1/2024 |
Last Dividend Amount | 0.29 |
Current Dividend Amount | 0.46 |
Dividend Aristocrat? | False |
Trailing Annual Dividend Rate | 0.75 |
Trailing Annual Dividend Yield | 3.07% |
Forward Annual Dividend Rate | 0.76 |
Forward Annual Dividend Yield | 3.09% |
5-Year Dividend Payments Count | 10 |
3-Year Average Dividend Yield | 2.57% |
5-Year Average Dividend Yield | 2.20% |
1-Year Dividend Growth Rate Percentage | 0.00% |
3-Year Dividend Growth Rate Percentage | 0.00% |
5-Year Dividend Growth Rate Percentage | 0.75% |
All-Time Dividend Growth Rate Percentage | -3.11% |
Dividend Payout Ratio | 125.00% |
Income Statement |
|
Quarterly Earnings Growth YOY | 98.30% |
Annual Earnings Growth | 17.94% |
Reported EPS 12 Trailing Months | 0.60 |
Reported EPS Past Year | 0.00 |
Reported EPS Prior Year | 0.35 |
Net Income Twelve Trailing Months | 396,528,832 |
Net Income Past Year | 263,000,000 |
Net Income Prior Year | 223,000,000 |
Quarterly Revenue Growth YOY | 7.60% |
5-Year Revenue Growth | 2.50% |
Balance Sheet |
|
Total Cash Most Recent Quarter | 302,000,000 |
Total Cash Past Year | 302,000,000 |
Total Cash Prior Year | 350,000,000 |
Net Cash Position Most Recent Quarter | -1,873,000,000 |
Net Cash Position Past Year | -1,873,000,000 |
Long Term Debt Past Year | 2,175,000,000 |
Long Term Debt Prior Year | 2,565,000,000 |
Total Debt Most Recent Quarter | 2,175,000,000 |
Equity to Debt Ratio Past Year | 0.71 |
Equity to Debt Ratio Most Recent Quarter | 0.71 |
Total Stockholder Equity Past Year | 5,217,000,000 |
Total Stockholder Equity Prior Year | 5,259,000,000 |
Total Stockholder Equity Most Recent Quarter | 5,217,000,000 |
Options |
|
Put/Call Ratio | 0.00 |
Has Options | Options Chain |
Liquidity Rating | |
Technical Analysis |
|
Yahoo Finance Chart | Yahoo Finance Chart |
MACD | -0.44 |
MACD Signal | -0.55 |
20-Day Bollinger Lower Band | 23.50 |
20-Day Bollinger Middle Band | 26.21 |
20-Day Bollinger Upper Band | 28.93 |
Beta | 0.51 |
RSI | 42.27 |
50-Day SMA | 26.58 |
200-Day SMA | 30.62 |
System |
|
Modified | 4/27/2024 11:44:44 AM EST |